Related Experiment Video
Updated: Jun 13, 2026
High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
Critical limb ischemia
Insights
Critical limb ischemia (CLI) treatment decisions are complex, balancing surgical bypass, endovascular procedures, and amputation. Evidence is needed to guide optimal patient care for peripheral arterial disease.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Arterial Disease Management
Background:
- Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease, characterized by rest pain, ulcers, or gangrene due to arterial occlusive disease.
- Historically, open surgical bypass was the primary revascularization strategy, but endovascular techniques have expanded treatment options.
- Primary amputation remains an option for select patients unsuitable for revascularization.
Purpose of the Study:
- To review current treatment strategies for critical limb ischemia (CLI).
- To discuss the roles of open surgical bypass, endovascular therapy, and primary amputation in CLI management.
- To highlight the need for evidence-based guidelines for clinical and cost-effective CLI treatment decisions.
Main Methods:
- Review of existing literature and clinical practice guidelines for critical limb ischemia (CLI).
- Analysis of treatment outcomes based on disease location (aortoiliac vs. infrainguinal) and patient factors.
- Individualized treatment decision-making based on life expectancy, functional status, disease anatomy, and surgical risk.
Main Results:
- Endovascular therapy is first-line for most aortoiliac disease, while surgical bypass is preferred for severe cases.
- For infrainguinal disease, vein bypass is favored for suitable patients with a 2-year survival expectancy.
- Endovascular therapy is considered for patients with limited life expectancy, lack of usable vein, or high surgical risk.
Conclusions:
- Treatment decisions for CLI must be individualized, considering patient-specific factors and disease characteristics.
- While endovascular and surgical options are expanding, definitive evidence for optimal strategy selection is still lacking.
- Primary amputation or palliative care may be appropriate for patients with unreconstructable disease or severe comorbidities.
Abstract:
Critical limb ischemia (CLI), defined as chronic ischemic rest pain, ulcers, or gangrene attributable to objectively proven arterial occlusive disease, is the most advanced form of peripheral arterial disease. Traditionally, open surgical bypass was the only effective treatment strategy for limb revascularization in this patient population. However, during the past decade, the introduction and evolution of endovascular procedures have significantly increased treatment options. In a certain subset of patients for whom either surgical or endovascular revascularization may not be appropriate, primary amputation remains a third treatment option. Definitive high-level evidence on which to base treatment decisions, with an emphasis on clinical and cost effectiveness, is still lacking. Treatment decisions in CLI are individualized, based on life expectancy, functional status, anatomy of the arterial occlusive disease, and surgical risk. For patients with aortoiliac disease, endovascular therapy has become first-line therapy for all but the most severe patterns of occlusion, and aortofemoral bypass surgery is a highly effective and durable treatment for the latter group. For infrainguinal disease, the available data suggest that surgical bypass with vein is the preferred therapy for CLI patients likely to survive 2 years or more, and for those with long segment occlusions or severe infrapopliteal disease who have an acceptable surgical risk. Endovascular therapy may be preferred in patients with reduced life expectancy, those who lack usable vein for bypass or who are at elevated risk for operation, and those with less severe arterial occlusions. Patients with unreconstructable disease, extensive necrosis involving weight-bearing areas, nonambulatory status, or other severe comorbidities may be considered for primary amputation or palliative measures.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Related Concept Videos
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
01:27Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
01:30Peripheral Artery Disease I: Introduction
01:26Peripheral Artery Disease IV: Nursing Management
01:23Peripheral Artery Disease V: Postoperative Nursing Management
01:27Peripheral Artery Disease III: Interprofessional Care